Chapman KR - Search Results

1

Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.

Kerstjens HAM, Maspero J, Chapman KR, van Zyl-Smit RN, Hosoe M, Tanase AM, Lavecchia C, Pethe A, Shu X, D'Andrea P; IRIDIUM trial investigators. Kerstjens HAM, et al. Among authors: chapman kr. Lancet Respir Med. 2020 Oct;8(10):1000-1012. doi: 10.1016/S2213-2600(20)30190-9. Epub 2020 Jul 9. Lancet Respir Med. 2020. PMID: 32653074 Clinical Trial.

2

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH, Knight A, Malo JL, Mazza JA, Moote DW, Small P, et al. Kesten S, et al. Among authors: chapman kr. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):622-5. doi: 10.1164/ajrccm/144.3_Pt_1.622. Am Rev Respir Dis. 1991. PMID: 1892303 Clinical Trial.

3

A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma.

Chapman KR, Bryant D, Marlin GE, Mitchell C, Ruffin R, Inouye T, Pedersen B, Koskinen S, Osen SS, Ringdal N, et al. Chapman KR, et al. Am Rev Respir Dis. 1989 Mar;139(3):688-93. doi: 10.1164/ajrccm/139.3.688. Am Rev Respir Dis. 1989. PMID: 2647007 Clinical Trial.

4

Regular vs as-needed inhaled salbutamol in asthma control.

Chapman KR, Kesten S, Szalai JP. Chapman KR, et al. Lancet. 1994 Jun 4;343(8910):1379-82. doi: 10.1016/s0140-6736(94)92520-8. Lancet. 1994. PMID: 7910880 Clinical Trial.

5

Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma.

Chapman KR, Friberg K, Balter MS, Hyland RH, Alexander M, Abboud RT, Peters S, Jennings BH. Chapman KR, et al. Ann Allergy Asthma Immunol. 1997 Jan;78(1):59-63. doi: 10.1016/s1081-1206(10)63373-x. Ann Allergy Asthma Immunol. 1997. PMID: 9012623 Clinical Trial.

6

Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma.

Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, McClean P, Slutsky AS, Zamel N, Chapman KR. Silkoff PE, et al. Among authors: chapman kr. Am J Respir Crit Care Med. 1999 Mar;159(3):940-4. doi: 10.1164/ajrccm.159.3.9805044. Am J Respir Crit Care Med. 1999. PMID: 10051277 Clinical Trial.

7

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.

Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M. Chapman KR, et al. Can Respir J. 1999 Jan-Feb;6(1):45-51. doi: 10.1155/1999/894803. Can Respir J. 1999. PMID: 10202220 Free article. Clinical Trial.

8

Improving patient compliance with asthma therapy.

Chapman KR, Walker L, Cluley S, Fabbri L. Chapman KR, et al. Respir Med. 2000 Jan;94(1):2-9. doi: 10.1053/rmed.1999.0667. Respir Med. 2000. PMID: 10714473 Free article. Review.

9

Effectiveness and safety of salmeterol in nonspecialist practice settings.

D'Urzo AD, Chapman KR, Cartier A, Hargreave FE, Fitzgerald M, Tesarowski D. D'Urzo AD, et al. Among authors: chapman kr. Chest. 2001 Mar;119(3):714-9. doi: 10.1378/chest.119.3.714. Chest. 2001. PMID: 11243947 Clinical Trial.

10

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.

Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR. Renzi PM, et al. Among authors: chapman kr. Respir Med. 2010 Apr;104(4):510-7. doi: 10.1016/j.rmed.2009.10.025. Epub 2009 Nov 26. Respir Med. 2010. PMID: 19944581 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page